JP6335188B2 - 眼疾患の治療における使用のためのタンパク質ｓｌｕｒｐ−１ - Google Patents

眼疾患の治療における使用のためのタンパク質ｓｌｕｒｐ−１ Download PDF

Info

Publication number
JP6335188B2
JP6335188B2 JP2015546050A JP2015546050A JP6335188B2 JP 6335188 B2 JP6335188 B2 JP 6335188B2 JP 2015546050 A JP2015546050 A JP 2015546050A JP 2015546050 A JP2015546050 A JP 2015546050A JP 6335188 B2 JP6335188 B2 JP 6335188B2
Authority
JP
Japan
Prior art keywords
composition
slurp
group
protein
corneal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015546050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502558A5 (https=
JP2016502558A (ja
Inventor
ジャン−マルク コンベット
ジャン−マルク コンベット
カトリーヌ デローシェ
カトリーヌ デローシェ
クレール アバディー
クレール アバディー
セバスチャン モウズ
セバスチャン モウズ
ジュリアン ペリーノ
ジュリアン ペリーノ
Original Assignee
ブライトプラス ホールディング リミテッド
ブライトプラス ホールディング リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ブライトプラス ホールディング リミテッド, ブライトプラス ホールディング リミテッド filed Critical ブライトプラス ホールディング リミテッド
Publication of JP2016502558A publication Critical patent/JP2016502558A/ja
Publication of JP2016502558A5 publication Critical patent/JP2016502558A5/ja
Application granted granted Critical
Publication of JP6335188B2 publication Critical patent/JP6335188B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
JP2015546050A 2012-12-07 2013-12-09 眼疾患の治療における使用のためのタンパク質ｓｌｕｒｐ−１ Expired - Fee Related JP6335188B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12196007.4 2012-12-07
EP12196007.4A EP2740485B1 (en) 2012-12-07 2012-12-07 Protein slurp-1 for use in the treatment of ocular diseases
PCT/EP2013/075981 WO2014087022A1 (en) 2012-12-07 2013-12-09 Protein slurp-1 for use in the treatment of ocular diseases

Publications (3)

Publication Number Publication Date
JP2016502558A JP2016502558A (ja) 2016-01-28
JP2016502558A5 JP2016502558A5 (https=) 2017-01-19
JP6335188B2 true JP6335188B2 (ja) 2018-05-30

Family

ID=47297008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015546050A Expired - Fee Related JP6335188B2 (ja) 2012-12-07 2013-12-09 眼疾患の治療における使用のためのタンパク質ｓｌｕｒｐ−１

Country Status (15)

Country Link
US (1) US10098925B2 (https=)
EP (1) EP2740485B1 (https=)
JP (1) JP6335188B2 (https=)
KR (1) KR20150108351A (https=)
CN (1) CN105188731B (https=)
AU (1) AU2013353957B2 (https=)
BR (1) BR112015013215A2 (https=)
CA (1) CA2891201A1 (https=)
CL (1) CL2015001520A1 (https=)
EA (1) EA201591095A1 (https=)
IL (1) IL239078A0 (https=)
MX (1) MX2015006779A (https=)
SG (2) SG10201705592YA (https=)
WO (1) WO2014087022A1 (https=)
ZA (1) ZA201503747B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2740485B1 (en) * 2012-12-07 2018-10-31 Brightpulse Holding LTD. Protein slurp-1 for use in the treatment of ocular diseases
EP3689327B1 (fr) * 2019-01-24 2025-03-12 Organes Tissus Régénération Réparation Remplacement Composition pharmaceutique dans le traitement de lésions pulmonaires
CN114601915B (zh) * 2022-03-25 2023-04-07 四川大学华西医院 Slurp1蛋白在制备预防或治疗皮肤弹性纤维疾病的药物中的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
AU2004229237B2 (en) * 2003-04-16 2009-06-04 Merck Serono Sa Use of SLURP-1 for treating diseases related to acetylcholine receptors dysfunction
US20100303788A1 (en) * 2009-05-29 2010-12-02 Allergan, Inc. Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases
CA2806143A1 (en) * 2010-07-30 2012-02-02 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mb H Drug delivery devices and growth factor formulations for accelerated wound healing
EP3848055A1 (en) * 2011-06-03 2021-07-14 Ophidion Inc. Compositions and methods for transport across the blood brain barrier
US9132193B2 (en) * 2012-11-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Use of Slurp1 as an imunomodulatory molecule in the ocular surface
CA2890424C (en) * 2012-11-08 2020-11-17 Yamaguchi University Therapeutic agent for keratoconjunctive disorders
EP2740485B1 (en) * 2012-12-07 2018-10-31 Brightpulse Holding LTD. Protein slurp-1 for use in the treatment of ocular diseases

Also Published As

Publication number Publication date
IL239078A0 (en) 2015-07-30
EP2740485A1 (en) 2014-06-11
SG11201503658XA (en) 2015-06-29
CN105188731B (zh) 2019-02-05
SG10201705592YA (en) 2017-08-30
BR112015013215A2 (pt) 2018-02-06
CN105188731A (zh) 2015-12-23
CA2891201A1 (en) 2014-06-12
EP2740485B1 (en) 2018-10-31
ZA201503747B (en) 2016-03-30
AU2013353957A1 (en) 2015-05-28
CL2015001520A1 (es) 2016-05-20
US20150320831A1 (en) 2015-11-12
JP2016502558A (ja) 2016-01-28
EA201591095A1 (ru) 2015-11-30
KR20150108351A (ko) 2015-09-25
AU2013353957B2 (en) 2018-05-17
WO2014087022A1 (en) 2014-06-12
MX2015006779A (es) 2015-10-29
US10098925B2 (en) 2018-10-16

Similar Documents

Publication Publication Date Title
TW201615187A (zh) 用於舒緩及減輕近視之醫藥組合物及其製備方法與用途
Barsegian et al. Corneal neuropathy: an underrated manifestation of diabetes mellitus
JP2025181979A (ja) 角膜の混濁および瘢痕化の予防および治療のための組成物および方法
CA3144419A1 (en) Methods of promoting vasculogenesis
Acosta et al. Treatment of corneal ulcers with platelet rich plasma
JP6335188B2 (ja) 眼疾患の治療における使用のためのタンパク質ｓｌｕｒｐ−１
Wu et al. Chitosan-based thermosensitive hydrogel with long-term release of murine nerve growth factor for neurotrophic keratopathy
JP2023550661A (ja) ドライアイ治療用薬の調製におけるｐ５５ｐｉｋ阻害剤の応用
US5145680A (en) Eye drop formulation useful for treating lesions of corneal epithelium
KR20220047979A (ko) 안구 건조증에 대한 tsg6 폴리펩티드 단편
KR102023827B1 (ko) 안구 건조증 질환의 치료 및/또는 예방을 위한 짧은 합성 펩티드의 용도
CN101537172A (zh) 一种含有重组人角质细胞生长因子-2滴眼液及其制备方法
Yi et al. A Time‐Programmed Bilayer Wound Dressing for Dynamic Microenvironment Modulation and Full‐Thickness Regeneration in Diabetic Wounds
KR20150033788A (ko) 안지오제닌을 유효성분으로 함유하는 각막 내피의 창상 치료용 약학조성물
CN102258771A (zh) 重组水蛭素在防治糖尿病性白内障中的应用
Ji et al. Efficacy and Safety of Amphotericin B with Autologous Serum for Fungal Corneal Ulcer
CN111346217B (zh) 多肽tdl23的新用途
Mao et al. Bioactive thermoresponsive fibronectin–Pluronic F127 hydrogel for sustained ocular delivery with corneal regeneration and anti-inflammatory effects
Anitua et al. Regenerative effect of Plasma rich in growth factors-transparent membrane in an animal model of photorefractive keratectomy. Comparative study with amniotic membrane.
Elkhawaga et al. Assessment of Corneal Epithelial Healing Rate after Pterygium Excision When Using 2% Hyaluronic Acid.
WO2023182468A1 (ja) 創傷治療用組成物
WO2023150791A1 (en) Peptides and methods of use thereof in treating ocular disorders
CN115721656A (zh) 包含瑞巴派特或其盐的药物组合物及其制备方法和在制备眼用制剂中的用途
WO2023215269A1 (en) Lacripep promotes neuroregeneration and maintains epithelial progenitor cell identity
KR20130006110A (ko) 제대혈청을 포함하는 재발성 각막미란의 치료용 약학조성물

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20150907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161128

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171017

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180316

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180403

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180427

R150 Certificate of patent or registration of utility model

Ref document number: 6335188

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees